Epsilon M&A Deal Report - Homeperf

Transaction Multiples for the Valuation of Private Companies

Private Group led by Parquest Capital > Homeperf

Announced Date : 24 September 2015

Type : MBO (Management Buy Out) ,SBO (Secondary Buy Out) ,Exit

Deal Value : Yes

Acquirer : Private Group led by Parquest Capital

Target: Homeperf

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 1997 by Gaël Donadey, Homeperf provides home healthcare services specializing i ...

No EMAT : 93868

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1228

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
04/09/2018	Cattleya Finance	Parfums Caron	France	**
05/02/2016	Vivalto Sante	Clinique de L'Europe	France	***

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database